Switzerland: manufacture of pharmaceutical products production value 2020

The production value of the basic pharmaceutical products and pharmaceutical preparations manufacturing industry in Switzerland increased by 3.5 billion euros (+3.73 percent) in 2020. With 96.6 billion euros, the production value thereby reached its highest value in the observed period. Notably, the production value in this industry continuously increased over the last years.
The value of production is defined by Eurostat as the amount actually produced by the unit, based on sales, including changes in stocks and the resale of goods and services.

Find more statistics on the basic pharmaceutical products and pharmaceutical preparations manufacturing industry in Switzerland with key insights such as turnover and personnel costs.

Production value of the manufacture of basic pharmaceutical products and pharmaceutical preparations in Switzerland from 2011 to 2020 (in million euros)

Characteristic	Annual production value in million euros
2020	96,579
2019	93,109.3
2018	83,731.6
2017	79,424.4
2016	74,142
2015	70,487.5
2014	60,815.1
2013	59,462.1
2012	58,855.8
2011	51,367.6

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

March 2023

More information

Region

Switzerland

Survey time period

2011 to 2020

Supplementary notes

The source adds the following information: Production value measures the amount actually produced by the unit, based on sales, including changes in stocks and the resale of goods and services. The production value is defined as turnover, plus or minus the changes in stocks of finished products, work in progress and goods and services purchased for resale, minus the purchases of goods and services for resale, plus capitalised production, plus other operating income (excluding subsidies). Income and expenditure classified as financial or extra-ordinary in company accounts is excluded from production value.
Data coverage corresponds to Section C21 of NACE Rev2.

Citation formats